MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Glaxosmithkline Asia Private Limited

U15209DL1995PTC073278ActivePrivateUnlisted
Last updated: 2026-06-10
30
Compliance Health · F
3 / 9 signals passed

Glaxosmithkline Asia Private Limited is a Private Indian company incorporated in 1995 and based in Delhi, India. Glaxosmithkline Asia Private Limited operates in Food & Beverages (NIC 15209) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
1995
31 years old
State
Delhi
Sector
Food & Beverages
NIC 15209
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
GLAXOSMITHKLINE ASIA PRIVATE LIMITEDTRACXN · PUBLIC DATA
Brand GLAXOSMITHKLINE ASIA PRIVATE LIMITED · Legal entity Glaxosmithkline Asia Private Limited

GLAXOSMITHKLINE ASIA PRIVATE LIMITED is the legal entity of GSK.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
1,210
Stage
—
HQ
—
Founded
1995
Source: Tracxn (public profile) · joined to MCA on CIN U15209DL1995PTC073278

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
15209
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Food & Beverages
ROC
—
Website
https://www.newmediawire.com/news/lixte-biotechnology-holdings-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk-7084832
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
KB
Kunal Bhatia
Additional Director
2.0y · Ahmedabad · DIN 1399096
PN
Priya Nair
Additional Director
3.3y · Bengaluru · DIN 7760593
SG
Sneha Gupta
Director
3.3y · New Delhi · DIN 6167920
Get the full board of directors

Directors, DINs & appointment history for Glaxosmithkline Asia Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2524 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2425 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2327 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Glaxosmithkline Asia Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
603344248Axis Bank Ltd(Bank)₹4.49 Cr27 Jan 2020Satisfied
670104052Axis Bank Ltd(Bank)₹9.40 Cr27 Jan 2022Open
146736854Kotak Mahindra Bank Ltd(Bank)₹12.08 Cr12 Mar 2021Open
196064037State Bank of India(Bank)₹18.51 Cr12 Mar 2020Open
225964364State Bank of India(Bank)₹3.57 Cr12 Mar 2021Open
See registered charges & lenders

Charge IDs, lenders & amounts for Glaxosmithkline Asia Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹86.09 Cr₹-4.95 Cr₹73.84 Cr₹123.79 Cr404
FY2023-24₹74.23 Cr₹-3.16 Cr₹53.16 Cr₹102.64 Cr186
FY2022-23₹68.14 Cr₹-2.58 Cr₹42.76 Cr₹97.21 Cr72
FY2021-22₹44.35 Cr₹-3.19 Cr₹24.93 Cr₹55.11 Cr128
Gain deeper financial insights of this entity

Audited financials & ratios for Glaxosmithkline Asia Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹86.09 Cr₹74.23 Cr₹68.14 Cr₹44.35 Cr
Other income₹2.60 Cr₹1.13 Cr₹1.95 Cr₹96.03 L
Total income₹88.69 Cr₹75.36 Cr₹70.09 Cr₹45.31 Cr
Total expenses₹95.03 Cr₹79.41 Cr₹73.39 Cr₹49.39 Cr
Profit before tax₹-6.44 Cr₹-4.11 Cr₹-3.36 Cr₹-4.15 Cr
Profit / (Loss) after tax₹-4.95 Cr₹-3.16 Cr₹-2.58 Cr₹-3.19 Cr
Balance sheet
Equity / Net worth₹73.84 Cr₹53.16 Cr₹42.76 Cr₹24.93 Cr
Borrowings₹26.98 Cr₹24.37 Cr₹21.51 Cr₹8.11 Cr
Current liabilities₹26.85 Cr₹26.20 Cr₹16.90 Cr₹9.44 Cr
Total liabilities₹49.95 Cr₹49.48 Cr₹54.44 Cr₹30.19 Cr
Current assets₹45.37 Cr₹47.07 Cr₹45.44 Cr₹26.25 Cr
Cash & equivalents₹16.09 Cr₹8.84 Cr₹8.48 Cr₹4.38 Cr
Total assets₹123.79 Cr₹102.64 Cr₹97.21 Cr₹55.11 Cr
Employees40418672128
Gain deeper financial insights of this entity

Audited financials & ratios for Glaxosmithkline Asia Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹86.09 Cr+19.4%+3.4%+17.0%
Profit after Tax₹-4.95 Cr-10.6%+23.2%+6.1%
Net Worth₹73.84 Cr-6.4%+27.7%+13.6%
Employees404-2.6%+27.6%+18.8%
Gain deeper financial insights of this entity

Audited financials & ratios for Glaxosmithkline Asia Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹86.09 Cr₹-4.95 Cr-5.76%-5.39%-6.71%-4.00%0.37₹21.31 L
FY2023-24₹74.23 Cr₹-3.16 Cr-4.26%+12.04%-5.95%-3.08%0.46₹39.91 L
FY2022-23₹68.14 Cr₹-2.58 Cr-3.79%-1.55%-6.04%-2.66%0.50₹94.64 L
FY2021-22₹44.35 Cr₹-3.19 Cr-7.19%+7.91%-12.80%-5.79%0.33₹34.65 L
Gain deeper financial insights of this entity

Audited financials & ratios for Glaxosmithkline Asia Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters151,51,96991.97%
Institutional Investors11,85,0543.30%
Public & Others142,64,5084.72%
See the full shareholding pattern

Promoter, institutional & public holding for Glaxosmithkline Asia Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

20 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P0

Top 10 in Food & Beverages

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Mygreens
Delhi · Inc 2003
Paid-up
Revenue
C · 63
06
Manikant Nutritions Foods Private Limited
Himachal Pradesh · Inc 2012
Paid-up
Revenue
C · 63
07
Balaji Oil
Tamil Nadu · Inc 2020
Paid-up
Revenue
C · 63
08
Klasseleather
West Bengal · Inc 2002
Paid-up
Revenue
C · 63
09
Gopal Snacks Limited
Gujarat · Inc 2009
Paid-up
Revenue
C · 63
10
Paid-up
Revenue
C · 63

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Glaxosmithkline Asia Private Limited

When was Glaxosmithkline Asia Private Limited incorporated?
Glaxosmithkline Asia Private Limited was incorporated in 1995. Its CIN is U15209DL1995PTC073278 and it is registered with the relevant Registrar of Companies.
Where is Glaxosmithkline Asia Private Limited located?
Glaxosmithkline Asia Private Limited is headquartered in Delhi.
What sector does Glaxosmithkline Asia Private Limited operate in?
Glaxosmithkline Asia Private Limited operates in the Food & Beverages sector (NIC code 15209), classified as Indian Non-Govt Company.
Who are the directors of Glaxosmithkline Asia Private Limited?
Director details for Glaxosmithkline Asia Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Glaxosmithkline Asia Private Limited?
Glaxosmithkline Asia Private Limited has authorized capital of — and paid-up capital of —.
Does Glaxosmithkline Asia Private Limited have any open charges?
Glaxosmithkline Asia Private Limited has no open MCA-registered charges on record.
What is Glaxosmithkline Asia Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Glaxosmithkline Asia Private Limited is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.